SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-012033
Filing Date
2023-07-20
Accepted
2023-07-20 17:30:43
Documents
14
Period of Report
2023-07-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230718x8k.htm   iXBRL 8-K 46360
2 EX-10.2 tmb-20230718xex10d2.htm EX-10.2 34303
3 EX-10.3 tmb-20230718xex10d3.htm EX-10.3 86305
  Complete submission text file 0001558370-23-012033.txt   302938

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20230718.xsd EX-101.SCH 3136
5 EX-101.LAB tmb-20230718_lab.xml EX-101.LAB 15265
6 EX-101.PRE tmb-20230718_pre.xml EX-101.PRE 9929
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230718x8k_htm.xml XML 4668
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 231100618
SIC: 2834 Pharmaceutical Preparations